 |
|
|
|
|
Publicly Traded Biotechnology & Medical Device
Companies with Headquarters in Washington State
The following includes publicly traded biotechnology and medical device
companies headquartered in Washington State. Hyper links to company web
sites and stock exchange are provided allowing you to obtain additional information about
a specific company.
| Company/Location |
Sector |
IPO |
Exchg. |
Symbol |
Aptevo Therapeutics
Seattle, WA |
Biotechnology |
2016 |
NASDAQ |
APVO |
Atossa Genetics Inc.
Seattle, WA |
Biotechnology |
2009 |
NASDAQ |
ATOS |
BioLife Solutions, Inc.
Bothell, WA |
Biotechnology |
1998 |
OTCBB |
BLFS |
Cell Therapeutics
Seattle, WA |
Biotechnology |
1997 |
NASDAQ |
CTIC |
Cocrystal Pharma, Inc.
Bothell, WA |
Pharmaceutical |
2007 |
OTC BB |
COCP |
CytoDyn Inc.
Vancouver, WA |
Biotechnology |
1994 |
OTCQB |
CYDY |
Emergent BioSolutions Inc. (formerly Trubion) (1)
Seattle, WA |
Biotechnology |
2006 |
NYSE |
EBS |
HaloSource, Inc.
Bothell, WA |
Biotechnology |
1998 |
LSE |
HALO.LN |
Helix BioMedix, Inc.
Bothell, WA |
Biotechnology |
2000 |
OTCQB |
HXBM |
IsoRay, Inc.
Richland, WA |
Device |
2005 |
AMEX |
ISR |
Juno Therapeutics
Seattle, WA |
Biotechnology |
2005 |
NASDAQ |
JUNO |
Marina Biotech, Inc.
Bothell, WA |
Pharmaceutical |
1983 |
OTCQX |
MRNA |
NanoString Technologies, Inc.
Seattle, WA |
Biotechnology |
2003 |
NASDAQ |
NSTG |
Omeros Corporation
Bothell, WA |
Pharmaceutical |
2009 |
NASDAQ |
OMER |
OncoGenex Pharmaceuticals
Bothell, WA |
Pharma |
1991 |
NASDAQ |
OGXI |
PhaseRx
Seattle, WA |
Biotechnology |
2006 |
NASDAQ |
PZRX |
Seattle Genetics, Inc.
Bothell, WA |
Biotechnology |
2004 |
NASDAQ |
SGEN |
ZymoGenetics, Inc. (2)
Seattle, WA |
Biotechnology |
2002 |
NYSE |
BMY |
_____________________
(1) Emergent BioSolutions completed acquisition of Trubion Pharmaceuticals October 28, 2010.
(2) Bristol-Myers Squibb completed acquisition of ZymoGenetics, Inc. October 12, 2010.
Information is believed accurate but is not guaranteed.
|
|
|
|
|
|
